Zamecnik, C. R. et al. An autoantibody signature predictive for multiple sclerosis. Nat. Med. 30, 1300–1308 (2024).

Article  CAS  PubMed  Google Scholar 

Gross, C. C. et al. Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories. Sci. Transl. Med. 16, eade8560 (2024).

Article  CAS  PubMed  Google Scholar 

Kavaliunas, A. et al. Importance of early treatment initiation in the clinical course of multiple sclerosis. Mult. Scler. 23, 1233–1240 (2017).

Article  PubMed  Google Scholar 

University of California San Francisco MS-EPIC Team et al. Long-term evolution of multiple sclerosis disability in the treatment era. Ann. Neurol. 80, 499–510 (2016).

Article  PubMed Central  Google Scholar 

De Stefano, N. et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology 74, 1868–1876 (2010).

Article  PubMed  Google Scholar 

Suthiphosuwan, S. et al. Paramagnetic rim sign in radiologically isolated syndrome. JAMA Neurol. 77, 653–655 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375, 296–301 (2022).

Article  CAS  PubMed  Google Scholar 

Cortese, M. et al. Serologic response to the Epstein-Barr virus peptidome and the risk for multiple sclerosis. JAMA Neurol. 81, 515–524 (2024).

Article  PubMed  Google Scholar 

Bjornevik, K. et al. Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis. JAMA Neurol. 77, 58–64 (2020).

Article  PubMed  Google Scholar 

Bar-Or, A. et al. Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials. EBioMedicine 93, 104662 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar